Attempts to understand genetic disorders of lipoprotein metabolism, such as familial hypercholesterolemia and type III hyperlipoproteinemia, have so far been made by looking for abnormalities of protein structure and function in individuals with clearly defined diseases. Now, advances in recombinant DNA technology are making it possible to search for a defective gene even when no specific protein abnormality has been identified. Using this technology, we have recently isolated and completely characterized the normal human apolipoprotein A-I (apo A-I) gene and we showed that it is physically linked with the apolipoprotein C-III (apo C-III) gene. In addition, we showed that these genes are convergently transcribed and that a DNA insertion in the apo A-I gene is related to apo A-I-apo C-III deficiency in the plasma of patients with premature atherosclerosis. The specific objectives in this proposal are (a) to isolate and characterize the apo A-I-apo C-III gene complex from the apo A-I-apo C-III deficient patients, (b) to isolate, characterize and study the origin of the inserted DNA in the apo A-I gene of these patients, and (c) to investigate the possible effect of this DNA insertion in the expression of apo A-I and apo C-III genes of these patients. This analysis will take place by constructing a genomic library from these patients from which both apo A-I and apo C-III genes can be isolated and sequenced. Functional analysis of the apo A-I-apo C-III complex from both normal individuals and these patients will be studied by using the papilloma virus eukaryotic vector system. The same genomic library constructed from the apo A-I-apo C-III deficient patients will be used to isolate and study the DNA insertion occurring in their apo A-I gene. Abnormalities in lipoprotein metabolism contribute significantly to coronary atherosclerosis and heart disease which are the number one cause of death in the United States. The type of studies proposed here have already produced a simple test by which diagnosis of homozygotes or heterozygotes for the DNA insertion in the apo A-I gene related to the development of premature atherosclerosis can be carried out. In addition, elucidation of the mechanisms by which these genes are controlled may provide the basis by which early diagnosis and treatment of atherosclerosis may be accomplished.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL032032-02
Application #
3343244
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1984-07-01
Project End
1987-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
Ginsburg, G S; Ozer, J; Karathanasis, S K (1995) Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4. J Clin Invest 96:528-38
Mietus-Snyder, M; Sladek, F M; Ginsburg, G S et al. (1992) Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. Mol Cell Biol 12:1708-18
Widom, R L; Rhee, M; Karathanasis, S K (1992) Repression by ARP-1 sensitizes apolipoprotein AI gene responsiveness to RXR alpha and retinoic acid. Mol Cell Biol 12:3380-9
Lamon-Fava, S; Sastry, R; Ferrari, S et al. (1992) Evolutionary distinct mechanisms regulate apolipoprotein A-I gene expression: differences between avian and mammalian apoA-I gene transcription control regions. J Lipid Res 33:831-42
Widom, R L; Ladias, J A; Kouidou, S et al. (1991) Synergistic interactions between transcription factors control expression of the apolipoprotein AI gene in liver cells. Mol Cell Biol 11:677-87
Rottman, J N; Widom, R L; Nadal-Ginard, B et al. (1991) A retinoic acid-responsive element in the apolipoprotein AI gene distinguishes between two different retinoic acid response pathways. Mol Cell Biol 11:3814-20
Antonarakis, S E; Oettgen, P; Chakravarti, A et al. (1988) DNA polymorphism haplotypes of the human apolipoprotein APOA1-APOC3-APOA4 gene cluster. Hum Genet 80:265-73
Sastry, K N; Seedorf, U; Karathanasis, S K (1988) Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types. Mol Cell Biol 8:605-14
Karathanasis, S K; Ferris, E; Haddad, I A (1987) DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci U S A 84:7198-202
Karathanasis, S K; Yunis, I; Zannis, V I (1986) Structure, evolution, and tissue-specific synthesis of human apolipoprotein AIV. Biochemistry 25:3962-70

Showing the most recent 10 out of 17 publications